 Phuong Le
Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head and Neck Neoplasms | 11 | 2023 | 542 | 1.380 |
Why?
| | Neoplastic Stem Cells | 6 | 2020 | 379 | 1.040 |
Why?
| | Carcinoma, Squamous Cell | 8 | 2019 | 625 | 1.010 |
Why?
| | Wnt Signaling Pathway | 2 | 2018 | 170 | 0.940 |
Why?
| | Cell Communication | 1 | 2018 | 300 | 0.530 |
Why?
| | Tumor Microenvironment | 2 | 2020 | 631 | 0.490 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2014 | 39 | 0.450 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2014 | 207 | 0.400 |
Why?
| | Recombinant Fusion Proteins | 1 | 2014 | 648 | 0.370 |
Why?
| | Xenograft Model Antitumor Assays | 8 | 2020 | 812 | 0.320 |
Why?
| | Antineoplastic Agents | 3 | 2016 | 2053 | 0.280 |
Why?
| | Hedgehog Proteins | 3 | 2015 | 187 | 0.230 |
Why?
| | Mice, Nude | 4 | 2018 | 682 | 0.210 |
Why?
| | Hyaluronan Receptors | 2 | 2020 | 96 | 0.200 |
Why?
| | B7-H1 Antigen | 1 | 2023 | 195 | 0.190 |
Why?
| | Cetuximab | 3 | 2015 | 94 | 0.170 |
Why?
| | SOXB1 Transcription Factors | 2 | 2020 | 57 | 0.170 |
Why?
| | Mice | 12 | 2023 | 16915 | 0.170 |
Why?
| | Neoplasms | 1 | 2014 | 2449 | 0.160 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2020 | 44 | 0.160 |
Why?
| | Tumor Cells, Cultured | 2 | 2018 | 942 | 0.160 |
Why?
| | Animals | 15 | 2023 | 35307 | 0.160 |
Why?
| | Stem Cell Niche | 1 | 2019 | 53 | 0.160 |
Why?
| | Mouth Neoplasms | 1 | 2019 | 84 | 0.150 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2018 | 49 | 0.150 |
Why?
| | Peptides, Cyclic | 1 | 2020 | 256 | 0.150 |
Why?
| | Cell Line, Tumor | 7 | 2020 | 3201 | 0.140 |
Why?
| | Salivary Gland Neoplasms | 1 | 2018 | 33 | 0.140 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2013 | 758 | 0.140 |
Why?
| | Neoplasm Invasiveness | 1 | 2018 | 483 | 0.140 |
Why?
| | Veratrum Alkaloids | 2 | 2014 | 19 | 0.130 |
Why?
| | Cell Proliferation | 3 | 2019 | 2374 | 0.130 |
Why?
| | Disease Models, Animal | 4 | 2020 | 4057 | 0.130 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2016 | 26 | 0.130 |
Why?
| | Immunotherapy | 1 | 2020 | 592 | 0.130 |
Why?
| | ErbB Receptors | 3 | 2016 | 605 | 0.130 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2015 | 1555 | 0.120 |
Why?
| | Hematopoietic Stem Cells | 1 | 2018 | 381 | 0.120 |
Why?
| | Replication Protein A | 1 | 2014 | 12 | 0.110 |
Why?
| | DNA-Activated Protein Kinase | 1 | 2014 | 15 | 0.110 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2014 | 45 | 0.110 |
Why?
| | Homologous Recombination | 1 | 2014 | 23 | 0.110 |
Why?
| | Stromal Cells | 1 | 2014 | 105 | 0.110 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2020 | 958 | 0.110 |
Why?
| | Radiation Tolerance | 1 | 2014 | 98 | 0.110 |
Why?
| | Melanoma | 1 | 2020 | 729 | 0.110 |
Why?
| | Immunophenotyping | 3 | 2019 | 310 | 0.100 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2018 | 572 | 0.100 |
Why?
| | Leukemia, Radiation-Induced | 1 | 2012 | 4 | 0.100 |
Why?
| | Sulfones | 1 | 2013 | 108 | 0.100 |
Why?
| | Microsatellite Instability | 1 | 2012 | 37 | 0.100 |
Why?
| | Glycine | 1 | 2013 | 165 | 0.100 |
Why?
| | DNA Replication | 1 | 2014 | 227 | 0.100 |
Why?
| | Gamma Rays | 1 | 2012 | 54 | 0.100 |
Why?
| | Proto-Oncogene Proteins | 2 | 2013 | 635 | 0.100 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2018 | 1344 | 0.090 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1173 | 0.090 |
Why?
| | Mice, Inbred NOD | 2 | 2023 | 588 | 0.080 |
Why?
| | Trans-Activators | 1 | 2012 | 388 | 0.080 |
Why?
| | Phosphatidylinositol 3-Kinases | 3 | 2020 | 360 | 0.080 |
Why?
| | Apoptosis | 1 | 2018 | 2498 | 0.080 |
Why?
| | Nuclear Proteins | 1 | 2014 | 659 | 0.080 |
Why?
| | Humans | 16 | 2023 | 129248 | 0.080 |
Why?
| | RNA, Messenger | 1 | 2016 | 2703 | 0.080 |
Why?
| | Immunohistochemistry | 3 | 2019 | 1691 | 0.080 |
Why?
| | Signal Transduction | 4 | 2016 | 4926 | 0.080 |
Why?
| | Dose-Response Relationship, Radiation | 2 | 2020 | 132 | 0.070 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2012 | 592 | 0.060 |
Why?
| | Papillomaviridae | 2 | 2016 | 114 | 0.060 |
Why?
| | Mutation | 4 | 2018 | 3710 | 0.050 |
Why?
| | Cell Cycle Proteins | 2 | 2020 | 584 | 0.050 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2016 | 396 | 0.050 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2023 | 232 | 0.050 |
Why?
| | Zinc Finger E-box-Binding Homeobox 1 | 1 | 2020 | 24 | 0.040 |
Why?
| | Feedback, Physiological | 1 | 2020 | 76 | 0.040 |
Why?
| | Peptide Chain Elongation, Translational | 1 | 2020 | 18 | 0.040 |
Why?
| | Radiotherapy Dosage | 1 | 2020 | 251 | 0.040 |
Why?
| | Heterografts | 1 | 2019 | 131 | 0.040 |
Why?
| | Chemoradiotherapy | 1 | 2020 | 208 | 0.040 |
Why?
| | Hyaluronic Acid | 1 | 2020 | 214 | 0.040 |
Why?
| | DNA Repair | 1 | 2020 | 206 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 192 | 0.040 |
Why?
| | Biomarkers | 2 | 2019 | 3966 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 399 | 0.040 |
Why?
| | Monocytes | 1 | 2020 | 551 | 0.030 |
Why?
| | DNA Damage | 1 | 2020 | 383 | 0.030 |
Why?
| | Cell Cycle | 1 | 2020 | 589 | 0.030 |
Why?
| | Retinal Dehydrogenase | 1 | 2016 | 30 | 0.030 |
Why?
| | Carcinogenesis | 1 | 2018 | 213 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 2016 | 256 | 0.030 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2016 | 101 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2019 | 1290 | 0.030 |
Why?
| | Spheroids, Cellular | 1 | 2016 | 77 | 0.030 |
Why?
| | Maximum Tolerated Dose | 1 | 2015 | 193 | 0.030 |
Why?
| | Cadherins | 1 | 2016 | 188 | 0.030 |
Why?
| | Zinc Finger Protein GLI1 | 1 | 2014 | 23 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 1005 | 0.030 |
Why?
| | Cell Division | 1 | 2016 | 796 | 0.030 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2014 | 37 | 0.030 |
Why?
| | Female | 5 | 2020 | 68543 | 0.030 |
Why?
| | Checkpoint Kinase 1 | 1 | 2014 | 30 | 0.030 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2016 | 327 | 0.030 |
Why?
| | Cricetulus | 1 | 2014 | 108 | 0.030 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 66 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2015 | 645 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2016 | 428 | 0.030 |
Why?
| | CHO Cells | 1 | 2014 | 154 | 0.030 |
Why?
| | Cricetinae | 1 | 2014 | 278 | 0.030 |
Why?
| | Antigens, CD | 1 | 2016 | 489 | 0.030 |
Why?
| | Serine | 1 | 2014 | 138 | 0.030 |
Why?
| | Receptor, Notch2 | 1 | 2013 | 15 | 0.030 |
Why?
| | Receptor Cross-Talk | 1 | 2013 | 21 | 0.030 |
Why?
| | Gonanes | 1 | 2013 | 27 | 0.030 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2013 | 81 | 0.030 |
Why?
| | Alphapapillomavirus | 1 | 2013 | 40 | 0.030 |
Why?
| | Cesium Radioisotopes | 1 | 2012 | 1 | 0.030 |
Why?
| | Linear Energy Transfer | 1 | 2012 | 3 | 0.030 |
Why?
| | Chromatids | 1 | 2012 | 8 | 0.030 |
Why?
| | Receptor, Notch1 | 1 | 2013 | 61 | 0.030 |
Why?
| | Mice, Inbred CBA | 1 | 2012 | 52 | 0.030 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2014 | 201 | 0.020 |
Why?
| | Gene Silencing | 1 | 2013 | 190 | 0.020 |
Why?
| | Protein Kinases | 1 | 2014 | 318 | 0.020 |
Why?
| | Chromosome Aberrations | 1 | 2012 | 148 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2018 | 2871 | 0.020 |
Why?
| | Up-Regulation | 1 | 2014 | 839 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2012 | 313 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1688 | 0.020 |
Why?
| | Male | 4 | 2020 | 63501 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1584 | 0.020 |
Why?
| | Gene Expression | 1 | 2015 | 1466 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 874 | 0.020 |
Why?
| | Iron | 1 | 2012 | 281 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2630 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1204 | 0.020 |
Why?
| | Single-Cell Analysis | 1 | 2012 | 275 | 0.020 |
Why?
| | Papillomavirus Infections | 1 | 2013 | 297 | 0.020 |
Why?
| | Phosphorylation | 1 | 2014 | 1710 | 0.020 |
Why?
| | Computational Biology | 1 | 2013 | 595 | 0.020 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2013 | 756 | 0.020 |
Why?
| | Middle Aged | 2 | 2019 | 31087 | 0.020 |
Why?
| | Transcription Factors | 1 | 2014 | 1647 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2015 | 10199 | 0.010 |
Why?
| | Aged | 1 | 2019 | 22032 | 0.010 |
Why?
|
|
Le's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|